Loss of receptors for transforming growth factor beta in human T-cell malignancies. - Wikidata - wikimedia - TriplyDB

Loss of receptors for transforming growth factor beta in human T-cell malignancies.

Loss of receptors for transforming growth factor beta in human T-cell malignancies.

http://www.wikidata.org/entity/Q35546848

about

The emerging role of Twist proteins in hematopoietic cells and hematological malignancies Novel role of parathyroid hormone-related protein in the pathophysiology of the diabetic kidney: evidence from experimental and human diabetic nephropathy TGF-β - an excellent servant but a bad master Dysregulation of TGFβ1 Activity in Cancer and Its Influence on the Quality of Anti-Tumor Immunity The TGF-beta signaling inhibitor Smad7 enhances tumorigenicity in pancreatic cancer Elevated serum transforming growth factor beta1 levels in Epstein-Barr virus-associated diseases and their correlation with virus-specific immunoglobulin A (IgA) and IgM.Positive and negative regulation of type II TGF-beta receptor signal transduction by autophosphorylation on multiple serine residues.Staphylococcal enterotoxins stimulate lymphoma-associated immune dysregulation.Reduced surface expression of transforming growth factor beta receptor type II in mitogen-activated T cells from Sézary patients Generation of a mouse model of T-cell lymphoma based on chronic LPS challenge and TGF-β signaling disruption Betaglycan (TβRIII) is expressed in the thymus and regulates T cell development by protecting thymocytes from apoptosis.Lymphoma-like T cell infiltration in liver is associated with increased copy number of dominant negative form of TGFβ receptor II.t(8;9)(p22;p24)/PCM1-JAK2 activates SOCS2 and SOCS3 via STAT5.Studies of normal and neoplastic lymphocytes.Consistent loss of functional transforming growth factor beta receptor expression in murine plasmacytomas Chromosome 3 allelic losses and microsatellite alterations in transitional cell carcinoma of the urinary bladder Signaling by chimeric erythropoietin-TGF-beta receptors: homodimerization of the cytoplasmic domain of the type I TGF-beta receptor and heterodimerization with the type II receptor are both required for intracellular signal transduction.Loss of functional cell surface transforming growth factor beta (TGF-beta) type 1 receptor correlates with insensitivity to TGF-beta in chronic lymphocytic leukemia.Humanization of an anti-CCR4 antibody that kills cutaneous T-cell lymphoma cells and abrogates suppression by T-regulatory cells Role of transforming growth factor-beta in hematologic malignancies Defects in transforming growth factor-beta signaling cooperate with a Ras oncogene to cause rapid aneuploidy and malignant transformation of mouse keratinocytes.Mechanism-based epigenetic chemosensitization therapy of diffuse large B-cell lymphoma.Isolation and characterization of mutant cell lines defective in transforming growth factor beta signaling Molecular alterations and tumor suppressive function of the DUSP22 (Dual Specificity Phosphatase 22) gene in peripheral T-cell lymphoma subtypes.Malignant inflammation in cutaneous T-cell lymphoma-a hostile takeover Regulatory T cells and immunodeficiency in mycosis fungoides and Sézary syndrome.Sequence-specific enhancer binding protein is responsible for the differential expression of ERT/ESX/ELF-3/ESE-1/jen gene in human gastric cancer cell lines: Implication for the loss of TGF-beta type II receptor expression.Regulation of transforming growth factor-beta-receptor type I and type II messenger ribonucleic acid expression in the hamster ovary by gonadotropins and steroid hormones.Induction of transforming growth factor-beta receptor type II expression in estrogen receptor-positive breast cancer cells through SP1 activation by 5-aza-2'-deoxycytidine.Twist as a new prognostic marker in hematological malignancies.Cytokine receptor signaling is required for the survival of ALK- anaplastic large cell lymphoma, even in the presence of JAK1/STAT3 mutations.Bortezomib inhibits expression of TGF-β1, IL-10, and CXCR4, resulting in decreased survival and migration of cutaneous T cell lymphoma cells.Expression and autoregulation of transforming growth factor beta receptor mRNA in small-cell lung cancer cell lines.FOXP3 positive regulatory T-cells in cutaneous and systemic CD30 positive T-cell lymphoproliferations.A dominant inhibitory mutant of the type II transforming growth factor beta receptor in the malignant progression of a cutaneous T-cell lymphoma Evidence for an oncogenic role of AHI-1 in Sezary syndrome, a leukemic variant of human cutaneous T-cell lymphomas.Hyaluronan promotes signaling interaction between CD44 and the transforming growth factor beta receptor I in metastatic breast tumor cells.Biomarkers Provide Clues to Early Events in the Pathogenesis of Breast Implant-Associated Anaplastic Large Cell Lymphoma.Restoration of transforming growth factor-beta signaling enhances radiosensitivity by altering the Bcl-2/Bax ratio in the p53 mutant pancreatic cancer cell line MIA PaCa-2.Characterization of a newly established human pancreatic carcinoma cell line, UK Pan-1.

P2860

Q26822434-A9FAAE87-E60E-4884-9EA8-E020A229E95A Q26862757-284F386F-8EC3-456B-B895-C76012D39873 Q27025590-71437B1D-E75C-4D22-9459-A461A2F47232 Q28075996-3BA35AE1-430A-4802-A6C9-7F0BA3C79F8D Q28145081-5028D015-0EE2-470E-A445-213F6EBE9849 Q33799292-1163E1F5-6AED-4D66-8A4B-29E7E65B8C0D Q33886435-3013ECB5-9F40-4CCA-8819-DA5EAE66E941 Q33987080-C4439F6C-246F-4FA8-9C76-8BDAEA34D236 Q34230858-C2ADAE8E-68FC-4C1A-9753-03B25D7D1912 Q34405481-8E9BDB51-65EC-472E-A7DE-F9685E642089 Q34406454-AD6711D1-EF3C-4059-92C6-5D349B15443E Q34474492-805F740A-2E81-4F87-AE86-A06A24365CB4 Q34570939-954B2365-1A02-48A6-9C03-CD1799A3A376 Q34792478-8731BB50-E841-4920-88A9-9B9BB1EF8552 Q35671557-E92F90B7-3070-460C-B258-40B1EE1A22EE Q35782360-B97B2AE3-5424-4DD5-AC83-D6E28962FCAB Q35907449-7D30C45D-6A57-4F04-A72F-0B23EB14D930 Q36160563-9477B6F9-FCA7-47A8-B19E-2A969A879C24 Q36392832-2B0642B8-2DE3-4080-AE2D-C4DF0426F8C3 Q36399296-A931184B-125A-4B21-B779-8A99CA2BDF5F Q36776928-8BEECC9C-888E-4D40-A337-D6170F274845 Q37164915-185FDC77-EC08-4CCF-8453-E5430749AAEB Q37431065-51920AEA-C6DA-43EA-874E-F3CD25E85E19 Q37708848-C97AF0A0-5117-4357-A3DB-B954DD01B14C Q37723390-9170BA9B-45B5-40EE-BD14-FA8C21B76F2D Q37929548-DCEEC03B-8731-4887-B263-7098B3E337A1 Q38301666-F2306CF6-2A5F-4DA8-A1FD-37DCBE741F5C Q38312127-DC1E2C5C-225D-4C3F-9266-595EB366F344 Q38336378-06DB4201-A4D4-4728-85D2-B6A80CD3376C Q38552664-184163E1-97EA-4266-BB78-B899BA4CD87B Q38868306-09818010-729B-4EA8-80F6-2182270EB965 Q38909786-11F76714-4E78-446A-90D1-DC1BF8BA835C Q39992153-5E3CA520-25FA-4EDD-ACAD-FA552516BDEA Q40003943-8DBBFB68-A00E-4FA5-984C-934B02E9BBBA Q40019241-6B822A0A-4EDA-4899-B6C0-3C3570835DF2 Q40256227-7F49A51D-D258-4FC1-88EC-64D5C0EFFCBE Q40714989-C90AF14C-21FD-472E-9E25-DD6EE2181CA1 Q40754578-389D863B-1AC1-4026-8CA6-9B6DB4376465 Q40770497-7111BFD9-C147-4384-AFA0-EE6CCE49C091 Q40879460-C990D263-1F2E-40AC-BD48-96DF55555E65

P2860

Loss of receptors for transforming growth factor beta in human T-cell malignancies.

http://www.wikidata.org/entity/Q35546848

description

1994 nî lūn-bûn

@nan

1994 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

1994 թվականի հունիսին հրատարակված գիտական հոդված

@hy

1994年の論文

@ja

1994年論文

@yue

1994年論文

@zh-hant

1994年論文

@zh-hk

1994年論文

@zh-mo

1994年論文

@zh-tw

1994年论文

@wuu

name

Loss of receptors for transforming growth factor beta in human T-cell malignancies.

@ast

Loss of receptors for transforming growth factor beta in human T-cell malignancies.

@en

type

label

Loss of receptors for transforming growth factor beta in human T-cell malignancies.

@ast

Loss of receptors for transforming growth factor beta in human T-cell malignancies.

@en

prefLabel

Loss of receptors for transforming growth factor beta in human T-cell malignancies.

@ast

Loss of receptors for transforming growth factor beta in human T-cell malignancies.

@en

P1433

Q35546848-679861B4-8F95-4A62-9528-8B1E78E21F9E

P1476

Q35546848-317C98DF-9CE1-4EB7-B62D-FCDAD1176CC5

P2093

Q35546848-1AE1371D-4481-4E22-A2CF-598E4BE1D815

Q35546848-258B6268-0DA6-47FC-95E3-DD22FAA8B8B3

Q35546848-7225FE1F-9EAD-4E04-B35F-BBAD49FE7F9D

Q35546848-CE397BBE-5064-486C-9FEC-862C2B319DED

Q35546848-F6BFAC41-7808-4C14-8BFF-5EC0410B357A

P2860

Q35546848-1BC38C1F-B67C-4CBE-9BE5-A9DBE31FF3BC

Q35546848-1E16DDCB-6686-4CF1-AFCF-754BA1EFE73B

Q35546848-3C31833F-D186-4178-BBFE-AE70468CF6E6

Q35546848-49F002E3-0610-4A7F-8E94-0A00BE3DBB5D

Q35546848-5D9BFE67-F231-4EF9-9ED1-C7DE5F4F7B13

Q35546848-67D4764F-1C22-4A22-9D07-2D42441E274F

Q35546848-6F984790-9B41-4900-AEA8-CEF1927F80FB

Q35546848-7C852AD4-F503-411B-8BF3-467AF1C3E577

Q35546848-7F1E0665-AD1C-4BF3-9C2E-625D57DD115D

Q35546848-91613729-CE28-45CE-8E1B-8969AFA97B06

P304

Q35546848-6FDC2572-207E-491B-84FA-3E675E9ECD3C

P31

Q35546848-B4A91B00-83F6-4A51-9C3C-087A9CC3B49A

P356

Q35546848-3A5BBB7D-D3B9-4643-A20A-13F92BAEF258

P407

Q35546848-2D650078-FC1B-4D63-8884-12A6A1BC7EE2

P433

Q35546848-C5EBFAD6-105A-4073-9B82-323E61A0BBD1

P478

Q35546848-2F06B3DB-2231-4662-BDB6-5E15F7E1A887

P50

Q35546848-EC5445C9-0B4A-45A4-B95B-9B25D9EF1215

P577

Q35546848-3AAE4638-5B92-4D97-94E1-D05CBC7E4BCA

P5875

Q35546848-C1ED2625-8897-477F-A0DC-CEDC2EE88928

P698

Q35546848-EDAE91DD-C017-4610-B5F0-EB10139849F3

P932

Q35546848-18CCCDE5-A965-450B-8478-1874A16E1BA3

P356

PNAS.91.13.6002

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Loss of receptors for transforming growth factor beta in human T-cell malignancies

@en

P2093

D George

http://www.w3.org/2001/XMLSchema#string

M E Kadin

http://www.w3.org/2001/XMLSchema#string

M W Cavaille-Coll

http://www.w3.org/2001/XMLSchema#string

R Gertz

http://www.w3.org/2001/XMLSchema#string

S Cheifetz

http://www.w3.org/2001/XMLSchema#string

P2860

TGF beta signals through a heteromeric protein kinase receptor complex

Lymphomatoid papulosis. A continuing self-healing eruption, clinically benign--histologically malignant

Structure and expression of the membrane proteoglycan betaglycan, a component of the TGF-beta receptor system

The transforming growth factor-beta family

The transforming growth factor-beta receptor type III is a membrane proteoglycan. Domain structure of the receptor.

The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells.

Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro.

Immunohistochemical evidence of a role for transforming growth factor beta in the pathogenesis of nodular sclerosing Hodgkin's disease.

Production of transforming growth factor-beta activity by Ki-1 positive lymphoma cells and analysis of its role in the regulation of Ki-1 positive lymphoma growth.

The molecular and cellular basis of affinity maturation in the antibody response.

P304

6002-6006

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.91.13.6002

http://www.w3.org/2001/XMLSchema#string

P407

P433

13

http://www.w3.org/2001/XMLSchema#string

P478

91

http://www.w3.org/2001/XMLSchema#string

P50

Joan Massagué Solé

P577

1994-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

15183350

http://www.w3.org/2001/XMLSchema#string

P698

8016105

http://www.w3.org/2001/XMLSchema#string

P932

44125

http://www.w3.org/2001/XMLSchema#string